E-DRUG: EMA transparency proposal at odds with EU Clinical Trials Regulation
------------------------------------------------------------------------------------------------------
Dear E-Druggers
The European Medicines Agency’s (EMA) proposal regarding the specifications of the European Union clinical trials database can jeopardise the transparency advances obtained through the European Clinical Trials Regulation.
We call on the EMA to stay true to the Regulation and ensure that its implementation improves public access to scientific evidence about the effects of medicines on human health.
More details in the joint statement by Medicines in Europe Forum (MiEF), the International Society of Drug Bulletins (ISDB), the Association Internationale de la Mutualité (AIM), Health Action International (HAI) Europe at
http://english.prescrire.org/en/79/207/46302/4103/4089/SubReportDetails.aspx
Christophe Kopp
email:ckopp@prescrire.org
website:<http://english.prescrire.org>
email:ckopp@prescrire.org